Daniel M. S. MagalhãesI; Maurilio O. DeiningerI; Orlando Gomes de OliveiraI; John Allexander de FreitasI; Eugênia di Giuseppe DeiningerI
DOI: 10.21470/1678-9741-2021-0607
ABSTRACT
Introduction: Despite its survival benefits, bilateral internal thoracic artery (BITA) grafting is not commonly utilized due to concerns over deep sternal wound infection (DSWI). We observed the role of routine use of BITA and off-pump coronary artery bypass grafting (OPCABG) in the incidence of DSWI and associated risk factors.BITA = Bilateral internal thoracic artery
BMI = Body mass index
CABG = Coronary artery bypass grafting
COPD = Chronic obstructive pulmonary disease
DSWI = Deep sternal wound infection
ITA = Internal thoracic artery
OPCABG = Off-pump coronary artery bypass grafting
RITA = Right internal thoracic artery
SITA = Single internal thoracic artery
INTRODUCTION
Deep sternal wound infection (DSWI) is a serious complication after coronary artery bypass grafting (CABG), which increases its morbidity and mortality. Several retrospective clinical trials have documented an increased risk of these complications associated with bilateral internal thoracic artery (BITA) harvesting, especially in patients with diabetes, chronic obstructive pulmonary disease (COPD), and obesity[1].
The incidence of DSWI seems to be caused by the sternal ischemia that occurs after harvesting the BITA pedicle. Anatomical studies confirmed a decrease in sternal blood flow resulting from BITA dissection, and this was demonstrated by postoperative flow studies[2]. In order to minimize sternal complications, techniques such as skeletonized internal thoracic artery (ITA) dissection and low-energy electrocautery have been used[3]. Since these techniques were adopted, a reduction in wound infections has been reported when BITA grafts were removed, even in high-risk patients[3,4,5].
Despite the demonstrated benefits of BITA over the single internal thoracic artery (SITA) in reintervention-free long-term survival, many surgeons still resist routine adoption of BITA grafting[6,7]. The technical challenge, the longer time spent, and the risk of infection are the main factors for restricting this technique to only 4-5% of CABG procedures worldwide[8,9].
Some authors demonstrated that off-pump coronary artery bypass grafting (OPCABG), using skeletonized BITA, reduced postoperative complications, including wound infection, when compared to the conventional technique[10,11].
We hypothesize that OPCABG with BITA can be used routinely even in high-risk patients, including those with diabetes, COPD, and obesity, despite the risk of DSWI. This study retrospectively analyzed, over 10 years, all patients undergoing CABG in a single center, to identify the incidence of DSWI and associated risk factors.
METHODS
In this study, we performed a retrospective analysis of data from the hospital records of all patients undergoing isolated CABG in our service, in order to identify serious complications of the surgical wound. All patients were operated on by the same team of experienced surgeons.
The eligibility criterion was isolated CABG, therefore, patients undergoing combined procedures were excluded from this study. It was intended to perform OPCABG in all cases. From January 2010 to December 2020, a total of 2,211 patients underwent cardiac surgery, of which 1,207 (54.59%) were treated with isolated CABG.
Graft Selection
It was based on the following strategies: 1) patients with severe multivessel disease (> 75%) involving the left coronary arteries or left main obstruction superior to 50% received BITA grafts; and 2) for minor lesions or to revascularize the right coronary artery, great saphenous veins grafts were used as additional conduits; ITA arteries were harvested in a skeletonized fashion with a conventional monopolar scalpel at low energy levels. The graft arrangement included: in situ, composite, or aortocoronary bypass. Distal anastomosis was generally performed with 8-0 polypropylene suture. The right internal thoracic artery (RITA) was most often anastomosed to the region of the left anterior descending artery, crossing anteriorly the aorta, and the left internal thoracic artery was usually anastomosed to the circumflex artery system in this set. For complete myocardial revascularization, saphenous vein or radial artery grafts were used as additional conduits.
Perioperative Management
A few hours before surgery, the hairs around the surgical site were removed with clippers, and all patients were washed with a 2% chlorhexidine soap solution. In the operating room, traditional surgical scrubbing with a 2% chlorhexidine solution was performed. Before the skin incision, cefazolin (2 g) was initially administered, and additional doses (1 g) were administered every three hours during the procedure. The presternal space was closed with two layers of absorbable monofilament suture, followed by a continuous absorbable skin suture. Intravenous prophylactic antibiotics were administered after surgery for two days. During the procedure, blood glucose was routinely measured every two hours. An intravenous insulin infusion was given when blood glucose exceeded 150 mg/dL.
Deep Sternal Wound Infection
DSWI was defined as a wound infection involving muscle, bone, and/or the mediastinum that meets any of the following conditions: open wound, with excision of tissue or re-exploration of mediastinum, positive culture, or treatment with antibiotics - based on the United States of America Centers for Disease Control guidelines -, and included patients who received required wound debridement and re-stitching[12]. For analysis purposes, all patients who were readmitted at any time in their evolution due to DSWI were considered.
Statistical Analysis
Continuous variables are expressed as mean and standard deviation. The differences between groups were compared using Student’s t-test for normally distributed continuous data, or the Mann-Whitney U test for non-normally distributed continuous variables, and using the Fisher’s exact test for categorical variables. Multivariate analyses were performed by forward stepwise linear regression model. When dealing with continuous variables, in which the relationship with the outcome was not linear, we determined cutoff points, such as age, for example.
RESULTS
Preoperative Characteristics
A total of 1,207 patients were treated with isolated CABG, and only seven had DSWI (0.58%). Table 1 shows preoperative characteristics. The mean age was 72±6.8 years in DSWI vs. 65.14±9.9 years in no-DSWI group (P=0.067). The prevalence of diabetes mellitus (100% vs. 40.7%; P=0.001), hyperlipidemia (100% vs. 85.9%; P=0.045), and obesity (71.4% vs. 26.8%; P=0.017) were significant elevated in DSWI group, when compared with no-DSWI group.
| Demographic Characteristics | All (N=1,207) | Deep wound sternal wound infection
(N=7) |
No deep sternal wound infection (N=1,200) | P-value |
|---|---|---|---|---|
| Age (years) | 65.18 (±9.9) | 72 (±6.8) | 65.14 (±9.9) | 0.067 |
| Male | 863 (71.5) | 3 (42.9) | 860 (71.7) | 0.106 |
| Unstable angina | 241 (20.0) | 3 (42.9) | 238 (19.8) | 0.146 |
| New York Heart Association functional class - III/IV | 386 (32.0) | 2 (28.6) | 384 (32.0) | 0.846 |
| Previous myocardial infarction > 30 days | 628 (52.0) | 1 (14.3) | 627 (52.3) | 0.059 |
| Previous myocardial infarction < 30 days | 97 (8.0) | 1 (14.3) | 96 (8.0) | 0.542 |
| Smoking | 712 (59.0) | 4 (57.1) | 708 (59.0) | 0.921 |
| Diabetes | 495 (41.0) | 7 (100.0) | 488 (40.7) | 0.001 |
| Hyperlipidemia | 1,038 (86.0) | 7 (100.0) | 1,031 (85.9) | 0.045 |
| Obesity (BMI > 30) | 326 (27.0) | 5 (71.4) | 321 (26.8) | 0.017 |
| Hypertension | 809 (67.0) | 4 (57.1) | 805 (67.1) | 0.690 |
| Previous angioplasty | 422 (35.0) | 2 (28.6) | 420 (35.0) | 0.722 |
| Left ventricular ejection fraction (30% - 40%) | 36 (3.0) | 0 (0.0) | 36 (3.0) | 0.643 |
| Left ventricular ejection fraction (41% - 50%) | 217 (18.0) | 2 (28.6) | 210 (17.5) | 0.443 |
| Left ventricular ejection fraction (> 50%) | 954 (79.0) | 5 (71.4) | 957 (79.8) | 0.583 |
| Emergency surgery | 241 (20.0) | 2 (28.6) | 231 (19.3) | 0.358 |
| Chronic obstructive lung disease | 145 (12.0) | 2 (28.6) | 130 (10.8) | 0.173 |
BMI=body mass index
Operative Characteristics
Ninety-seven percent of surgeries were performed by OPCABG, with a conversion rate of 2.7% (Table 2). No significant difference was observed in DSWI incidence when surgery was converted from OPCABG (14.3% in DSWI group vs. 2.7% in no-DSWI group; P=0.209). No significant difference in DSWI incidence was observed when BITA (70.6%) or SITA (29.4%) were used (P=0.680). A no-touch aorta surgery was performed in 32.8%. In 65.1% of cases, RITA was used anteriorly crossing the aorta. The total number of distal anastomoses was 3,386 (mean of 2.8 anastomoses per patient). The operative mortality (in hospital) was significantly higher in patients with DSWI (28.57%) when compared with no-DSWI patients (1.25%; P<0.001).
| Surgical Aspects | All (N=1,207) | Deep sternal wound infection (N=7) |
No deep sternal wound infection (N=1,200) | P-value |
|---|---|---|---|---|
| OPCABG | 1,174 (97.3) | 6 (85.7) | 1,168 (97.3) | 0.180 |
| Conversion from OPCABG | 33 (2.7) | 1 (14.3) | 32 (2.7) | 0.209 |
| No-touch aorta | 396 (32.8) | 3 (42.9) | 393 (32.8) | 0.689 |
| Bilateral internal thoracic artery | 852 (70.6) | 6 (85.7) | 846 (70.5) | 0.459 |
| Single internal thoracic artery | 355 (29.4) | 1 (14.3) | 354 (29.5) | 0.459 |
| Right internal thoracic artery crossover | 786 (65.1) | 6 (85.7) | 778 (64.8) | 0.685 |
| Saphenous vein | 934 (77.4) | 4 (57.1) | 930 (77.5) | 0.525 |
| Number of distal anastomoses | 3,386 (2.8) | 18 (2.6) | 3,368 (2.8) | 0.448 |
| 64 (5.3) | 0 (0,0) | 64 (5.3) | ||
| 330 (27.3) | 3 (42.9) | 227 (18.9) | ||
| 612 (50.7) | 4 (57.1) | 608 (50.7) | ||
| 201 (16.7) | 0 (0,0) | 201 (16.8) | ||
| Operative mortality (in hospital) | 17 (1.4) | 2 (28.57) | 15 (1.25) | < 0.001 |
OPCABG=off-pump coronary artery bypass grafting
Risk
Linear regression analysis demonstrated that diabetes, unstable angina, previous myocardial infarction, left ventricular ejection fraction < 50%, and emergency surgery were strong independent risk factors for DSWI (Table 3).
| Characteristics | P-value |
|---|---|
| Age > 70 years | 0.0963 |
| Sex | 0.1610 |
| Unstable angina | 0.0064 |
| New York Heart Association functional class - III/IV | 0.0627 |
| Previous myocardial infarction > 30 days | 0.0009 |
| Previous myocardial infarction < 30 days | 0.3792 |
| Smoking | 0.9099 |
| Diabetes | 0.0001 |
| Hyperlipidemia | 0.0746 |
| Obesity (BMI > 30) | 0.2768 |
| Hypertension | 0.0705 |
| Previous angioplasty | 0.1489 |
| Left ventricular ejection fraction (30 - 40) | 0.6979 |
| Left ventricular ejection fraction (41 - 50) | 0.0074 |
| Left ventricular ejection fraction (> 50) | 0.5830 |
| Emergency surgery | 0.0002 |
| Chronic obstructive lung disease | 0.0508 |
BMI=body mass index
DISCUSSION
The present study using data from a single center showed satisfactory results of isolated OPCABG with a higher rate of BITA graft use (70.6%) and low incidence of DSWI (0.58%) and hospital mortality (1.4%).
The main reason why cardiovascular surgeons are hesitant to perform BITA grafts is DSWI, especially in patients with multiple preoperative risk factors such as diabetes mellitus, low ejection fraction, lung disease, and chronic kidney disease[13-15]. In fact, the present study showed that the rate of severe postoperative complications, including in-hospital mortality, was significantly higher in patients with DSWI (28.57%) compared to no-DSWI patients (1.25%) (P<0.001), demonstrating the severity of this complication. However, the survival benefits of the BITA graft for these high-risk patients have been also reported compared to the SITA graft surgery[6,7]. Therefore, a proper risk assessment of the DSWI is essential to minimize risk and maximize the long-term benefits derived from using BITA. The incidence of DSWI in the present cohort (0.58%) was acceptable compared to reports from various centers or national cohorts (1.4%-5.2%)[4,15,16]. The high prevalence of diabetes (41% in this cohort vs. 18.2%-33.3% in patients undergoing BITA graft in previous studies)[6,8,9,17,18], previous percutaneous coronary intervention (35% vs. 3.2% -16.7 in patients undergoing BITA graft in previous studies)[14,19,20], and the higher mean age (65.1±9.9 years vs. 56.0-60.1±5.5 years) are in agreement with the selection profile in which all patients were listed consecutively, better representing the “real-world” situation[6,8,18,21]. Regarding patients with diabetes, the incidence of DSWI receiving BITA grafts ranges from 2.9 to 11.6%[4,15,20,22] and in the present study it was 1.71%, which confirms the low incidence of DSWI in this cohort, even in high risk patients. OPCABG was performed in 97.3% of patients in this study. It is expected that OPCABG reduces the systemic perioperative inflammatory response; however, OPCABG has not been identified as an independent factor to reduce DSWI[17,20]. Despite a low conversion rate from OPCABG to on-pump CABG (2.7%), no significant difference was observed in DSWI incidence when surgery was converted from OPCABG (14.3% in DSWI group vs. 2.7% in no-DSWI group; P=0.209). The absence of difference may be related to the small number of converted cases. A larger number of patients would be needed to identify whether conversion would be a risk factor for DSWI. A recent sub-analysis of the Arterial Revascularization Trial clearly demonstrated that a skeletonized BITA reduces the risk of DSWI compared to a pedicled BITA[20]. Even with a high rate use of BITA (70.6%) in this study, there was no significant increase in DSWI compared to similar studies[14,18,20] or compared to SITA use (P=0.683), perhaps due to careful graft dissection by experienced surgeons, but this may not be applicable to surgeon training centers, for example. A lower incidence of DSWI in this cohort could be influenced by skeletonized use in all cases. The mean age was higher in DSWI group (72±6.8 years) vs. 65.14±9.9 years in no-DSWI group (P=0.067), despite not having reached a statistically significant difference. Perhaps a study with a greater number of cases could have shown a difference, since age is an additional risk factor for complications. The prevalence of diabetes mellitus (100% vs. 40.7%; P=0.001), hyperlipidemia (100% vs. 85.9%; P=0.045), and obesity (71.4% vs. 26.8%; P-0.017) were significant elevated in DSWI group, when compared with no-DSWI group. These findings are in agreement with some previous studies[14,18,20]. Often, obese diabetic patients are excluded from studies using BITA, due to the higher risk of infectious complications.
In the present risk model, diabetes mellitus has been recognized as the main risk factor for DSWI[16-18,22]. Preoperative hemodynamic status, such as an ejection fraction < 60%, is an independent risk factor for DSWI. These results are reasonable because a low output status has been recognized as a risk factor for infection[17,20]. Unstable angina and emergency surgery were independent risk factors too for DSWI in this study. These results may be in agreement with the greater severity of these patients, including the possible use of dual antiplatelet therapy at the time of surgery and a poor diabetes control, which can lead to longer surgical time and higher incidence of bleeding and infection.
Limitations
We must note several limitations in this study. It was a retrospective study using a single-center hospital database with no mortality long-term results. The results of this study may be biased because it is a single center, with a relatively low volume of surgeries and with a unique team of dedicated and experienced surgeons, which may not represent the “real-world” in high-volume institutions. Therefore, the choice of patients who will undergo BITA must be done carefully in most centers.
CONCLUSION
We reported the results and risks of DSWI after OPCABG BITA grafting from a single center; the results of routine use of BITA grafting were acceptable, and the incidence of hospital death after DSWI was higher than that with no-DSWI. The current data and risk model are informative to evaluate the risk of DSWI when performing OPCABG BITA grafting. Additional long-term prospective and multicenter studies are still needed to validate the routine use of BITA for all patients.
REFERENCES
1. Balachandran S, Lee A, Denehy L, Lin KY, Royse A, Royse C, et al.Risk factors for sternal complications after cardiac operations: a systematicreview. Ann Thorac Surg. 2016;102(6):2109-17.doi:10.1016/j.athoracsur.2016.05.047. [MedLine]
2. Sajja LR, Mannam G. Internal thoracic artery: anatomical andbiological characteristics revisited. Asian Cardiovasc Thorac Ann.2015;23(1):88-99. doi:10.1177/0218492314523629. [MedLine]
3. Sajja LR. Strategies to reduce deep sternal wound infection afterbilateral internal mammary artery grafting. Int J Surg. 2015;16(Pt B):171-8.doi:10.1016/j.ijsu.2014.11.017. [MedLine]
4. Raza S, Sabik JF 3rd, Masabni K, Ainkaran P, Lytle BW, BlackstoneEH. Surgical revascularization techniques that minimize surgical risk andmaximize late survival after coronary artery bypass grafting in patients withdiabetes mellitus. J Thorac Cardiovasc Surg. 2014;148(4):1257-64; discussion1264-6. doi:10.1016/j.jtcvs.2014.06.058. [MedLine]
5. Peterson MD, Borger MA, Rao V, Peniston CM, Feindel CM.Skeletonization of bilateral internal thoracic artery grafts lowers the risk ofsternal infection in patients with diabetes. J Thorac Cardiovasc Surg.2003;126(5):1314-9. doi:10.1016/s0022-5223(03)00808-0. [MedLine]
6. Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, CosgroveDM. The effect of bilateral internal thoracic artery grafting on survival during20 postoperative years. Ann Thorac Surg. 2004;78(6):2005-12; discussion 2012-4.doi:10.1016/j.athoracsur.2004.05.070.
7. Puskas JD, Sadiq A, Vassiliades TA, Kilgo PD, Lattouf OM. Bilateralinternal thoracic artery grafting is associated with significantly improvedlong-term survival, even among diabetic patients. Ann Thorac Surg.2012;94(3):710-5; discussion 715-6.doi:10.1016/j.athoracsur.2012.03.082.
8. Tabata M, Grab JD, Khalpey Z, Edwards FH, O'Brien SM, Cohn LH, etal. Prevalence and variability of internal mammary artery graft use incontemporary multivessel coronary artery bypass graft surgery: analysis of thesociety of thoracic surgeons national cardiac database. Circulation.2009;120(11):935-40. doi:10.1161/CIRCULATIONAHA.108.832444. [MedLine]
9. LaPar DJ, Crosby IK, Rich JB, Quader MA, Speir AM, Kern JA, et al.Bilateral internal mammary artery use for coronary artery bypass graftingremains underutilized: a propensity-matched multi-institution analysis. AnnThorac Surg. 2015;100(1):8-14; discussion 14-5.doi:10.1016/j.athoracsur.2015.02.088. [MedLine]
10. Kinoshita T, Asai T, Suzuki T. Off-pump bilateral skeletonizedinternal thoracic artery grafting in patients with chronic kidney disease. JThorac Cardiovasc Surg. 2015;150(2):315-21.e3.doi:10.1016/j.jtcvs.2015.04.058. [MedLine]
11. Sajja LR, Mannam G, Dandu SB, Sompalli S. Reduction of sternal woundinfections in diabetic patients undergoing off-pump coronary artery bypasssurgery and using modified pedicle bilateral internal thoracic artery harvesttechnique. J Thorac Cardiovasc Surg. 2012;144(2):480-5.doi:10.1016/j.jtcvs.2012.03.024. [MedLine]
12. Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Pawlaczyk R, et al.Pedicled and skeletonized single and bilateral internal thoracic artery graftsand the incidence of sternal wound complications: insights from the arterialrevascularization trial. J Thorac Cardiovasc Surg. 2016;152(1):270-6.doi:10.1016/j.jtcvs.2016.03.056. [MedLine]
13. Aldea GS, Bakaeen FG, Pal J, Fremes S, Head SJ, Sabik J, et al. Thesociety of thoracic surgeons clinical practice guidelines on arterial conduitsfor coronary artery bypass grafting. Ann Thorac Surg. 2016;101(2):801-9.doi:10.1016/j.athoracsur.2015.09.100. [MedLine]
14. Dai C, Lu Z, Zhu H, Xue S, Lian F. Bilateral internal mammary arterygrafting and risk of sternal wound infection: evidence from observationalstudies. Ann Thorac Surg. 2013;95(6):1938-45.doi:10.1016/j.athoracsur.2012.12.038. [MedLine]
15. Kieser TM, Lewin AM, Graham MM, Martin BJ, Galbraith PD, Rabi DM, etal. Outcomes associated with bilateral internal thoracic artery grafting: theimportance of age. Ann Thorac Surg. 2011;92(4):1269-75; discussion 1275-6.doi:10.1016/j.athoracsur.2011.05.083.
16. Gatti G, Soso P, Dell'Angela L, Maschietto L, Dreas L, Benussi B,Luzzati R, Sinagra G, et al. Routine use of bilateral internal thoracic arterygrafts for left-sided myocardial revascularization in insulin-dependent diabeticpatients: early and long-term outcomes. Eur J Cardiothorac Surg.2015;48(1):115-20. doi:10.1093/ejcts/ezu360. [MedLine]
17. Itagaki S, Cavallaro P, Adams DH, Chikwe J. Bilateral internalmammary artery grafts, mortality and morbidity: an analysis of 1 526 360coronary bypass operations. Heart. 2013;99(12):849-53.doi:10.1136/heartjnl-2013-303672. [MedLine]
18. Vrancic JM, Piccinini F, Camporrotondo M, Espinoza JC, Camou JI,Nacinovich F, et al. Bilateral internal thoracic artery grafting increasesmediastinitis: myth or fact? Ann Thorac Surg. 2017;103(3):834-9.doi:10.1016/j.athoracsur.2016.06.080. [MedLine]
19. Benedetto U, Caputo M, Gaudino M, Marsico R, Rajakaruna C, Bryan A,et al. Right internal thoracic artery or radial artery? A propensity-matchedcomparison on the second-best arterial conduit. J Thorac Cardiovasc Surg.2017;153(1):79-88.e4. doi:10.1016/j.jtcvs.2016.08.060. [MedLine]
20. Ohira S, Miyata H, Yamazaki S, Numata S, Motomura N, Takamoto S, etal. Deep sternal wound infection after bilateral internal thoracic arterygrafting: insights from a Japanese national database. J Thorac Cardiovasc Surg.2019;157(1):166-73.e1. doi:10.1016/j.jtcvs.2018.06.101.
21. Nakano J, Okabayashi H, Hanyu M, Soga Y, Nomoto T, Arai Y, et al.Risk factors for wound infection after off-pump coronary artery bypass grafting:should bilateral internal thoracic arteries be harvested in patients withdiabetes? J Thorac Cardiovasc Surg. 2008;135(3):540-5.doi:10.1016/j.jtcvs.2007.11.008. [MedLine]
22. Saito A, Miyata H, Motomura N, Ono M, Takamoto S; JapanCardiovascular Surgery Database Organization. Propensity-matched analysis ofbilateral internal mammary artery vs single internal mammary artery in 7702cases of isolated coronary artery bypass grafting. Eur J Cardiothorac Surg.2013;44(4):711-7. doi:10.1093/ejcts/ezt157. [MedLine]
Authors’Roles & Responsibilities
DMSM= Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published
MOD= Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published
Article receive on Thursday, December 9, 2021
Article accepted on Tuesday, May 17, 2022
All scientific articles published at rbccv.org are licensed under a Creative Commons license
All rights reserved 2017 / © 2024 Brazilian Society of Cardiovascular Surgery
DEVELOPMENT BY 
English PDF
Print
Send this article by email
How to cite this article
Submit a comment
Mendeley
Pocket
Share on Facebook
Share on Twitter